Scientists at the Shirley Ryan AbiilityLab in Chicago are studying whether an investigational drug can help the 300,000 Americans living with spinal cord.
New technologies dramatically improve post-stroke rehab israel21c.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from israel21c.org Daily Mail and Mail on Sunday newspapers.
NervGen Pharma Corp.: NervGen Pharma to Present Two Posters at the American Spinal Injury Association 51st Annual Scientific Meeting finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
NervGen Pharma Corp. , a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced today that Daniel Mikol, MD, Ph.D., Chief.